Trial · NCT04589845
Registered outcomes41
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 41
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | All Cohorts: Independent Review Committee (IRC)-assessed Objective Response Rate (ORR) Based on Confirmed Objective Response (OR) per Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1) | Approximately up to 12 years | Confirmed objective response indicates ≥4 weeks after initial documentation of response. |
| Secondary | All Cohorts: IRC-assessed Duration of Response (DOR) per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: IRC-assessed Clinical Benefit Rate (CBR) per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: IRC-assessed Progression-free Survival (PFS) per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: Investigator (INV)-assessed ORR per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: INV-assessed DOR per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: INV-assessed CBR per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: INV-assessed PFS per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: IRC- and INV-assessed Time to Central Nervous System (CNS) Progression per RECIST v1.1 | Approximately up to 12 years | |
| Secondary | All Cohorts: Overall Survival (OS) | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: IRC-assessed CNS-ORR per Response Assessment in Neuro-oncology (RANO) | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: IRC-assessed CNS-DOR per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: IRC-assessed CNS-CBR per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: IRC-assessed CNS-PFS per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: INV-assessed CNS-ORR per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: INV-assessed CNS-DOR per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: INV-assessed CNS-CBR per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, I, J, K: INV-assessed CNS-PFS per RANO | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, E, F, H, I, J, K, L, M, N: IRC-assessed ORR per International Neuroblastoma Response Criteria (INRC) | Approximately up to 12 years | |
| Secondary | Cohorts A, B, C, D, E, F, H, I, J, K, L, M, N: IRC-assessed DOR per INRC | Approximately up to 12 years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04589845/registered